Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Ling Lin

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|June 12, 2015
High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of DengueEtienne Simon-Loriere, Ren-Jye Lin, Sita Mint Kalayanarooj, et al.
Biochemical Pharmacology|July 22, 2023
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furinCheng-Wei Yang, Hsing-Yu Hsu, Yue-Zhi Lee, et al.
Biochemical Pharmacology|January 18, 2025
Corrigendum to "Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin" [Biochem. Pharmacol. 215 (2023) 115688]Cheng-Wei Yang, Hsing-Yu Hsu, Yue-Zhi Lee, et al.
Plos One|September 9, 2021
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamstersRakesh Kulkarni, Wen-Ching Chen, Ying Lee, et al.
The Lancet. Respiratory Medicine|October 16, 2021
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in TaiwanSzu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2020
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench studyKeng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, et al.
Scientific Reports|April 23, 2021
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challengeChia-En Lien, Yi-Jiun Lin, Charles Chen, et al.
NPJ Genomic Medicine|February 12, 2021
Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han ChineseChun-Yu Wei, Jenn-Hwai Yang, Erh-Chan Yeh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 26, 2023
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in TaiwanYen-Fang Huang, Fang-Chi Hsu, Jiunn-Jong Wu, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Cardio- and Neurotoxicity of Selected Anti-COVID-19 DrugsMartin W Nicholson, Ching-Ying Huang, Jyun-Yuan Wang, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|June 12, 2015
High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of DengueEtienne Simon-Loriere, Ren-Jye Lin, Sita Mint Kalayanarooj, et al.
Biochemical Pharmacology|July 22, 2023
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furinCheng-Wei Yang, Hsing-Yu Hsu, Yue-Zhi Lee, et al.
Biochemical Pharmacology|January 18, 2025
Corrigendum to "Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin" [Biochem. Pharmacol. 215 (2023) 115688]Cheng-Wei Yang, Hsing-Yu Hsu, Yue-Zhi Lee, et al.
Plos One|September 9, 2021
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamstersRakesh Kulkarni, Wen-Ching Chen, Ying Lee, et al.
The Lancet. Respiratory Medicine|October 16, 2021
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in TaiwanSzu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2020
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench studyKeng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, et al.
Scientific Reports|April 23, 2021
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challengeChia-En Lien, Yi-Jiun Lin, Charles Chen, et al.
NPJ Genomic Medicine|February 12, 2021
Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han ChineseChun-Yu Wei, Jenn-Hwai Yang, Erh-Chan Yeh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 26, 2023
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in TaiwanYen-Fang Huang, Fang-Chi Hsu, Jiunn-Jong Wu, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Cardio- and Neurotoxicity of Selected Anti-COVID-19 DrugsMartin W Nicholson, Ching-Ying Huang, Jyun-Yuan Wang, et al.
Pageof 30